Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2025 ARTÍCULOS , VIENDO DEL 76 AL 90

Unlocking the potential of EEG in Alzheimer's disease research: Current status and pathways to precision detection

Akbar F, Taj I, Usman SM, Imran AS, Khalid S, Ihsan I, Ali A, Yasin A.

Brain Res Bull. 2025 Apr;223:111281. doi: 10.1016/j.brainresbull.2025.111281. Epub 2025 Mar 7.

Linking Circadian Rhythms to Gut-Brain Axis Lipid Metabolism Associated With Endoplasmic Reticulum Stress in Alzheimer's Disease

Su J, Zhao L, Fu R, Tang Z.

CNS Neurosci Ther. 2025 Mar;31(3):e70329. doi: 10.1111/cns.70329.

Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances

Jiang Q, Liu J, Huang S, Wang XY, Chen X, Liu GH, Ye K, Song W, Masters CL, Wang J, Wang YJ.

Signal Transduct Target Ther. 2025 Mar 10;10(1):76. doi: 10.1038/s41392-025-02145-7.

Common Signaling Pathways in Cancer and Alzheimer's Disease May Point to New Treatments

Wu C, Jiang L, Zhong Y, Liu Z.

Curr Top Med Chem. 2025;25(22):2585-2609. doi: 10.2174/0115680266340314250303003647.

Vitamin K Properties in Stroke and Alzheimer's Disease: A Janus Bifrons in Protection and Prevention

Grimaldi L, Cavallaro RA, De Angelis D, Fuso A, Sancesario G.

Molecules. 2025 Feb 24;30(5):1027. doi: 10.3390/molecules30051027.

Exploring the Efficacy and Safety of Nutritional Supplements in Alzheimer's Disease

Gualtieri P, Frank G, Cianci R, Ciancarella L, Romano L, Ortoman M, Bigioni G, Nicoletti F, Falco MI, La Placa G, Di Renzo L.

Nutrients. 2025 Mar 6;17(5):922. doi: 10.3390/nu17050922.

Neuroprotection effect of bovine umbilical mesenchymal stem cell-conditioned medium on the rat model of Alzheimer's disease mediated by upregulation of BDNF and NGF and downregulation of TNF-α and IL-1β

Wihadmadyatami H, Zulfikar MA, Herawati H, Karnati S, Saragih GR, Aliffia D, Pratama DAOA, Handayani N, Kustiati U, Tirtosari DR, Tjahjono Y.

Open Vet J. 2025 Jan;15(1):151-161. doi: 10.5455/OVJ.2025.v15.i1.14. Epub 2025 Jan 31.

The blood-brain barrier as a treatment target for neurodegenerative disorders

Rust R, Sagare AP, Zhang M, Zlokovic BV, Kisler K.

Expert Opin Drug Deliv. 2025 May;22(5):673-692. doi: 10.1080/17425247.2025.2480654. Epub 2025 Mar 21.

Potential therapeutic targets for Alzheimer's disease: Fibroblast growth factors and their regulation of ferroptosis, pyroptosis and autophagy

Li Y, Yang C, Liu X, Shu J, Zhao N, Sun Z, Tabish MS, Hong Y, Liu E, Wei N, Sun M.

Neuroscience. 2025 May 7;573:42-51. doi: 10.1016/j.neuroscience.2025.03.009. Epub 2025 Mar 15.

Innovative approaches in acetylcholinesterase inhibition: a pathway to effective Alzheimer's disease treatment

Arora P, Swati, Rani S, Jha S, Gupta S, Kumar S.

Mol Divers. 2025 Dec;29(6):5367-5396. doi: 10.1007/s11030-025-11170-1. Epub 2025 Mar 24.

The Role of Glial Cell Senescence in Alzheimer's Disease

Alshaebi F, Sciortino A, Kayed R.

J Neurochem. 2025 Mar;169(3):e70051. doi: 10.1111/jnc.70051.

Alzheimer's Disease, β-Amyloid Peptides, and Ubiquitin-Proteasome System: Nutritherapeutic Insights

Simon PYR, David R.

Neurodegener Dis. 2025;25(2):76-87. doi: 10.1159/000545170. Epub 2025 Mar 25.

Advancements in Proteolysis Targeting Chimeras for Targeted Therapeutic Strategies in Alzheimer's Disease

Zhou Q, Wang W, Deng C.

Mol Neurobiol. 2025 Aug;62(8):9686-9709. doi: 10.1007/s12035-025-04838-0. Epub 2025 Mar 25.

Cholesterol-modifying strategies for Alzheimer disease: promise or fallacy?

Azarfar K, Decourt B, Sanchez Camacho B, Lawrence JJ, Omondi TR, Sabbagh MN.

Expert Rev Neurother. 2025 May;25(5):521-535. doi: 10.1080/14737175.2025.2483928. Epub 2025 Apr 3.

Updates and future perspectives on neuropsychiatric symptoms in Alzheimer's disease

Ruthirakuhan M, Guan DX, Mortby M, Gatchel J, Babulal GM.

Alzheimers Dement. 2025 Mar;21(3):e70079. doi: 10.1002/alz.70079.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias